Literature DB >> 1759330

Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma.

M Rossel1, C Billerey, H Bittard, P Ksiazek, D Alber, J P Revillard, D A Vuitton.   

Abstract

To assess the capacity of transitional cells to synthesize the release polymeric immunoglobulin receptor (pIg-R) in bladder carcinoma, we studied the localization of pIg-R in normal and tumor tissues and measured the levels of secretory component (SC) either in the free form or bound to Ig (S-IgA, S-IgM) in the serum and urine of 56 patients with transitional-cell carcinoma (TCC) of the bladder. In the normal bladder mucosa, pIg-R was localized in the cytoplasm and plasma membranes of the superficial cells and on all epithelial cell membranes. In TCC cases, 65% of those studied expressed pIg-R. A marked heterogeneity in pIg-R staining was observed in some tumors. Although a better expression of pIg-R in tumors with a well-preserved epithelial architecture was observed, no correlation was found between pIg-R expression and the grade or stage of the tumors in the patients under study. Three groups were established: (1) in TCC with no complications, serum levels of free SC and S-IgA were significantly increased; (2) in TCC with urinary infections (UI), serum levels of free SC and S-IgA were significantly higher than control values but lay within the same range observed in TCC with no complications and rates of urinary excretion of SC were significantly higher than those in normal subjects; (3) in TCC without UI but with hepatic disorders [high gamma-glutamyl transferase (GGT) activity], there was a correlation between serum S-IgA levels and GGT activity (r = 0.5, P less than 0.005) and serum SC levels were significantly higher than those observed in the other groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759330     DOI: 10.1007/bf00310151

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  Sandwich-type ELISA for free and bound secretory component in human biological fluids.

Authors:  C Vincent; J P Revillard
Journal:  J Immunol Methods       Date:  1988-02-10       Impact factor: 2.303

Review 2.  Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man.

Authors:  P Brandtzaeg
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

3.  Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues.

Authors:  W W Franke; D L Schiller; R Moll; S Winter; E Schmid; I Engelbrecht; H Denk; R Krepler; B Platzer
Journal:  J Mol Biol       Date:  1981-12-25       Impact factor: 5.469

4.  Bladder mucin: a scanning electron microscopy study in experimental cystitis.

Authors:  M J Balish; J Jensen; D T Uehling
Journal:  J Urol       Date:  1982-11       Impact factor: 7.450

5.  A solid phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum.

Authors:  D L Delacroix; J P Vaerman
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Secretory immunoglobulin A and inhibitory activity of bacterial adherence to epithelial cells in urine from patients with urinary tract infections.

Authors:  A Trinchieri; L Braceschi; D Tiranti; S Dell'Acqua; A Mandressi; E Pisani
Journal:  Urol Res       Date:  1990

7.  Circulating secretory component in breast neoplasms.

Authors:  D Kvale; T O Rognum; E Thorud; S D Fosså; J S Rø; P Brandtzaeg
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

8.  Elevated levels of secretory immunoglobulins A and M in serum of patients with large bowel carcinoma indicate liver metastasis.

Authors:  D Kvale; T O Rognum; P Brandtzaeg
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

9.  Secretory component: a glandular epithelial cell marker.

Authors:  J P Harris; M A South
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

10.  ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; J Schlom
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  9 in total

1.  Polymeric immunoglobulin receptor expression is predictive of poor prognosis in glioma patients.

Authors:  Huanjiang Niu; Kun Wang; Yirong Wang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

2.  Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.

Authors:  Jonna Berntsson; Sebastian Lundgren; Björn Nodin; Mathias Uhlén; Alexander Gaber; Karin Jirström
Journal:  J Ovarian Res       Date:  2014-02-26       Impact factor: 4.234

3.  Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis.

Authors:  Richard Fristedt; Jacob Elebro; Alexander Gaber; Liv Jonsson; Margareta Heby; Yulyana Yudina; Björn Nodin; Mathias Uhlén; Jakob Eberhard; Karin Jirström
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

4.  High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer.

Authors:  Ryotaro Ohkuma; Erica Yada; Shumpei Ishikawa; Daisuke Komura; Yutaro Kubota; Kazuyuki Hamada; Atsushi Horiike; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Midori Shida; Makoto Watanabe; Rie Onoue; Kiyohiro Ando; Junji Tsurutani; Kiyoshi Yoshimura; Tetsuro Sasada; Takeshi Aoki; Masahiko Murakami; Tomoko Norose; Nobuyuki Ohike; Masafumi Takimoto; Shinichi Kobayashi; Takuya Tsunoda; Satoshi Wada
Journal:  Oncol Rep       Date:  2020-05-11       Impact factor: 3.906

5.  Urinary peptide panel for prognostic assessment of bladder cancer relapse.

Authors:  Magdalena Krochmal; Kim E M van Kessel; Ellen C Zwarthoff; Iwona Belczacka; Martin Pejchinovski; Antonia Vlahou; Harald Mischak; Maria Frantzi
Journal:  Sci Rep       Date:  2019-05-21       Impact factor: 4.379

6.  Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.

Authors:  Dan Yan; Yi Chen
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

7.  Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma.

Authors:  Xuanwei Wang; Jingyu Du; Pengcheng Gu; Rilong Jin; Xiangjin Lin
Journal:  Mol Med Rep       Date:  2014-04-02       Impact factor: 2.952

8.  Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.

Authors:  Richard Fristedt; Alexander Gaber; Charlotta Hedner; Björn Nodin; Mathias Uhlén; Jakob Eberhard; Karin Jirström
Journal:  J Transl Med       Date:  2014-04-02       Impact factor: 5.531

9.  Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.

Authors:  Sebastian Lundgren; Jonna Berntsson; Björn Nodin; Patrick Micke; Karin Jirström
Journal:  J Ovarian Res       Date:  2016-04-06       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.